Results
Nine studies with 967 patients were included in our analysis. LVGLS was
significantly lower in the extra-cardiac sarcoidosis group as compared
to controls, SMD -3.98, 95% confidence interval (CI): -5.32, -2.64,
p< 0.001, also was significantly lower in patients who
suffered Major Cardiac Events(MCE), -3.89, 95% CI -6.14, -1.64,
p< 0.001 . GCS was significantly lower in the extra-cardiac
sarcoidosis group as compared to controls, SMD: -3.33, 95% CI -4.71,
-1.95, p< 0.001